OCT 17, 2017 9:00 AM PDT

Trial Showed Safety and Effectiveness of Brachytherapy Against Cervical Cancer

WRITTEN BY: Daniel Duan

Cervical cancer is a leading cause of cancer death among women in the developing world. Cancer treatments are often known for its unpredictable outcome, toxic side effects, and expensive cost. In the developing countries, the cost of treatment can quickly become an economic burden to patients’ family and healthcare agencies.

X-ray Image of brachytherapy application. Credit: Medscape Medical News

A five-year-long clinical trial conducted in India, Peru, South Africa, Brazil, Pakistan, Morocco, and Macedonia has confirmed the safety and effectiveness of a radiation treatment regimen for cervical cancer. Besides an external radiation beam delivered to the pelvic area, patients in this trial also received high doses of internal radiation known as the brachytherapy.

Brachytherapy is also called implant radiation therapy, during which a radioactive substance (such as cesium-137, iodine-131, and iridium-192) is placed directly into or close to the tumor in various tissues. Radioactive substances come in several different forms, including special applicators, thin wires, catheters, ribbons, needles, capsules or small seeds.

Different techniques are used for inserting the brachytherapy devices. Doctors can use long, hollow tubes that are loaded with the radioactive seeds, and inserted into the tissue where the seeds can be released. In some cases, catheters may be placed during surgery and later filled with radioactive material during brachytherapy sessions.

CT scans, ultrasound or other imaging techniques may be used to guide the devices into place and to ensure they're positioned in the most-effective locations. Depending on the type of implant, the radiation source will stay in place for minutes (for high dose application), days or permanently (both for low dose application).

Funded by the Division of Human Health at the International Atomic Energy Agency (IAEA), the study recruited a total of 601 patients with locally advanced cervical cancer. All patients received doses of pelvic external beam radiation therapy before the randomized trial. Half of them received four applications of brachytherapy at the radiation dose of 7 Gray (4 x 7 Gy), while the other half received two applications of 9 Gy (2 x 9 Gy). (Gray or Gy is a derived unit describing ionizing radiation dose. It is defined as the absorption of one joule of radiation energy per kilogram of matter.) 50% subjects in both dosage groups also received chemotherapy while the other half did not.

The results showed significantly superior tumor control in the group that received four times 7 Gy treatment, with 88 and 89 percent local control without and with chemotherapy. The rate of control in patients who received twice 9 Gy treatment was 78 and 75 percent without and with the addition of chemotherapy. The effect of chemotherapy did not influence overall survival, cancer-specific survival or tumor control in the cervix and surrounding region.

“Our trial demonstrates that combining pelvic radiation therapy with four fractions of 7 Gray (Gy) High-Dose Radiation (HDR) Brachytherapy is effective and safe for locally advanced cervical cancer,” said May Abdel-Wahab, director of the Division of Human Health at the IAEA. “The findings that chemotherapy did not significantly affect survival or tumor control in this setting seem to be different than the results of the meta-analysis from the Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration, which found six percent differences in local control due to the effect of chemotherapy,” she added.

However, it is important to note that the study was not powered to detect differences in local control that are less than 10 percent. In other words, the results of the two studies are not mutually exclusive.

The study can guide clinical teams that treat women with cervical cancer. It has also shown the feasibility of conducting global clinical trials, including in countries where access to research is more difficult. “The trial gives physicians data-supported guidance from a large, randomized study on what to expect in terms of outcomes if a regimen of two, 9-Gy fractions is used in resource-constrained settings,” said Abdel-Wahab.

Cancer Treatment: Brachytherapy. Credit: Nucleus Medical Media

Source: IAEA

About the Author
  • Graduated with a bachelor degree in Pharmaceutical Science and a master degree in neuropharmacology, Daniel is a radiopharmaceutical and radiobiology expert based in Ottawa, Canada. With years of experience in biomedical R&D, Daniel is very into writing. He is constantly fascinated by what's happening in the world of science. He hopes to capture the public's interest and promote scientific literacy with his trending news articles. The recurring topics in his Chemistry & Physics trending news section include alternative energy, material science, theoretical physics, medical imaging, and green chemistry.
You May Also Like
DEC 22, 2020
Chemistry & Physics
Improving transmission electron microscopy at nanoscale
DEC 22, 2020
Improving transmission electron microscopy at nanoscale
New research published in the journal Matter describes the development of a new kind of microscopy – this time at ...
JAN 29, 2021
Space & Astronomy
The Potential Range of Mass of Dark Matter Narrows Dramatically
JAN 29, 2021
The Potential Range of Mass of Dark Matter Narrows Dramatically
The part of the universe that we can see, which includes our planet and stars, makes up only around a quarter of the mas ...
JAN 31, 2021
Chemistry & Physics
Contaminated soil could be a source of chemical wealth
JAN 31, 2021
Contaminated soil could be a source of chemical wealth
Research released in the journal Science describes a new approach that can be used to synthesize valuable industry chemi ...
MAR 03, 2021
Chemistry & Physics
Exploring the swirlonic state of active matter
MAR 03, 2021
Exploring the swirlonic state of active matter
Research published in the journal Scientific Reports describes a new kind of active matter, termed a swirlonic state. As ...
MAR 19, 2021
Chemistry & Physics
Back to the basics: improving solvents for better batteries
MAR 19, 2021
Back to the basics: improving solvents for better batteries
New research published in the Journal of Physical Chemistry B from the University of Cincinnati describes using qua ...
MAY 03, 2021
Chemistry & Physics
What do advances in 3D printing techniques mean for tissue engineering?
MAY 03, 2021
What do advances in 3D printing techniques mean for tissue engineering?
New investigations into the field of customized tissue engineering are reported in the journal Bioprinting. The study wa ...
Loading Comments...